Literature DB >> 17292554

Thymoquinone attenuates proinflammatory responses in lipopolysaccharide-activated mast cells by modulating NF-kappaB nuclear transactivation.

Mohamed A El Gazzar1, Rabab El Mezayen, Mark R Nicolls, Stephen C Dreskin.   

Abstract

Activated mast cells play an important role in the development and maintenance of chronic inflammation by releasing proinflammatory cytokines such as Tumor necrosis factor alpha (TNFalpha). TNFalpha is a key mediator of immune and inflammatory responses as it controls the expression of inflammatory genes network and its overproduction contributes significantly to the pathological complications observed in many inflammatory diseases. We have previously shown that thymoquinone (TQ), which has broad anti-inflammatory activities, attenuates allergic inflammation in mice. In the present study, we investigated the effect of TQ on LPS-induced TNFalpha production in the rat basophil cell line, RBL-2H3. Stimulation of RBL-2H3 cells with LPS markedly increased TNFalpha production. TQ treatment significantly inhibited LPS-induced TNFalpha mRNA expression and protein production. To understand the mechanism by which TQ inhibited TNFalpha production, we examined its effects on activation of NF-kappaB transcription factor, which has been shown to be involved in regulating TNFalpha responses. LPS activated the NF-kappaB pathway, resulting in accumulation of NF-kappaB p65 and p50 subunits in the nucleus and activation of TNFalpha promoter. TQ administration to LPS-stimulated cells did not noticeably alter NF-kappaB cytosolic activation or nuclear expression as demonstrated by western blot analysis. Instead, TQ significantly increased the amount of the repressive NF-kappaB p50 homodimer, and simultaneously decreased the amount of transactivating NF-kappaB p65:p50 heterodimer, bound to the TNFalpha promoter as revealed by electrophoretic mobility shift and chromatin immunoprecipitation assays. Transient transfection of RBL-2H3 cells with TNFalpha promoter-driven luciferase gene constructs demonstrated that one of the three NF-kappaB binding sites in the TNFalpha promoter, the kappaB3 site, played a major role in the induction of TNFalpha promoter-driven luciferase gene expression by LPS, as well as in mediating the inhibitory effects of TQ on TNFalpha production, as TQ had minimal effect on the TNFalpha promoter-luciferase construct that lacks the kappaB3 site. Together, these results suggest that TQ attenuates the proinflammatory response in LPS-stimulated mast cells by modulating nuclear transactivation of NF-kappaB and TNFalpha production.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17292554     DOI: 10.1016/j.bbagen.2007.01.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  27 in total

Review 1.  Transcriptional control of the TNF gene.

Authors:  James V Falvo; Alla V Tsytsykova; Anne E Goldfeld
Journal:  Curr Dir Autoimmun       Date:  2010-02-18

2.  Thymoquinone Inhibits Neurogenic Inflammation Underlying Migraine Through Modulation of Calcitonin Gene-Related Peptide Release and Stabilization of Meningeal Mast Cells in Glyceryltrinitrate-Induced Migraine Model in Rats.

Authors:  Erkan Kilinc; Fatma Tore; Yasar Dagistan; Guler Bugdayci
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

3.  The effect of thymoquinone on the renal functions following ischemia-reperfusion injury in the rat.

Authors:  Fayez T Hammad; Loay Lubbad
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-12-25

4.  The Antioxidant Effects of Thymoquinone in Activated BV-2 Murine Microglial Cells.

Authors:  Makini K Cobourne-Duval; Equar Taka; Patricia Mendonca; David Bauer; Karam F A Soliman
Journal:  Neurochem Res       Date:  2016-09-01       Impact factor: 3.996

5.  Thymoquinone from nutraceutical black cumin oil activates Neu4 sialidase in live macrophage, dendritic, and normal and type I sialidosis human fibroblast cells via GPCR Galphai proteins and matrix metalloproteinase-9.

Authors:  Trisha M Finlay; Preethi Jayanth; Schammim Ray Amith; Alanna Gilmour; Christina Guzzo; Katrina Gee; Rudi Beyaert; Myron R Szewczuk
Journal:  Glycoconj J       Date:  2010-03-06       Impact factor: 2.916

6.  Chemopreventive and therapeutic potentials of thymoquinone in HepG2 cells: mechanistic perspectives.

Authors:  Abeer ElKhoely; Hafez F Hafez; Abeer M Ashmawy; Osama Badary; Ahmed Abdelaziz; Adel Mostafa; Samia A Shouman
Journal:  J Nat Med       Date:  2015-03-22       Impact factor: 2.343

7.  Contrasting actions of diesel exhaust particles on the pulmonary and cardiovascular systems and the effects of thymoquinone.

Authors:  Abderrahim Nemmar; Suhail Al-Salam; Shaheen Zia; Fatima Marzouqi; Amna Al-Dhaheri; Deepa Subramaniyan; Subramanian Dhanasekaran; Javed Yasin; Badreldin H Ali; Elsadig E Kazzam
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

8.  Thymoquinone increases the expression of neuroprotective proteins while decreasing the expression of pro-inflammatory cytokines and the gene expression NFκB pathway signaling targets in LPS/IFNγ -activated BV-2 microglia cells.

Authors:  Makini K Cobourne-Duval; Equar Taka; Patricia Mendonca; Karam F A Soliman
Journal:  J Neuroimmunol       Date:  2018-05-04       Impact factor: 3.478

9.  From here to eternity - the secret of Pharaohs: Therapeutic potential of black cumin seeds and beyond.

Authors:  Subhash Padhye; Sanjeev Banerjee; Aamir Ahmad; Ramzi Mohammad; Fazlul H Sarkar
Journal:  Cancer Ther       Date:  2008

10.  DYRK1A phoshorylates histone H3 to differentially regulate the binding of HP1 isoforms and antagonize HP1-mediated transcriptional repression.

Authors:  Suk Min Jang; Saliha Azebi; Guillaume Soubigou; Christian Muchardt
Journal:  EMBO Rep       Date:  2014-05-12       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.